- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Agnieszka Opalach
News 13 results
In the News · Source: La Lettre des Juristes d'Affaires, Le Monde du Droit and CFNEWS
April 26, 2022
Laurent Bensaid, Agnieszka Opalach and Julien Vicariot advise Montefiore Investment on its acquisition of Generix
Cases & Deals
April 22, 2022
Montefiore Investment on the proposed takeover bid for Generix
In the News · Source: Global Legal Chronicle, Le Monde du Droit, Option Droit & Affaires and La Lettre des Juristes d'Affaires
November 16, 2021
Laurent Bensaid, Agnieszka Opalach and Elisa Lirot advise Crédit Agricole and Gilbert Dupont with Acticor Biotech's SPAC IPO
In the News · Source: Le Monde du Droit
April 5, 2021
Laurent Bensaid, Agnieszka Opalach and Véronique Gédéon advise EDF ENR on its joint venture with Axtom
Events 1 results
Conference
November 5, 2019
Breakfast Seminar: W&I Insurances in M&A Deals Tested in Practice
Insights 3 results
Article · Source: Private Equity Magazine
March 21, 2022
The Keys to a Successful Take-private Operation
Article
May 20, 2020
Octroi d’une dérogation à OPA en cas de difficulté financière avérée de la cible
Client Alert
March 19, 2020
COVID-19: French corporate and securities laws implications